| abstract |
The present invention provides compositions and methods for generating novel non-human transgenic animals containing a modification of the gene of interest. The transgenic animal may produce an antibody, such as a human monoclonal antibody, specific for the product of the gene of interest that is functionally disrupted in the transgenic animal. Furthermore, the methods and compositions of the present invention are suitable for use in disease treatment, diagnosis and imaging. |